Sartar Therapeutics

Scorpion Therapeutics

This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.

SpringWorks Therapeutics

This biopharmaceutical company develops and commercialises targeted oncology medicines and therapies for patients with rare diseases and cancer.

Apim Therapeutics

This clinical-stage biotechnology company develops peptide drugs targeting cellular stress responses for patients with advanced cancers including ovarian cancer and sarcoma.

iDRx

This biopharmaceutical company develops precision combination therapies targeting genetic drivers and resistance mutations for patients with gastrointestinal stromal tumours.

Salarius Pharmaceutical

This company develops epigenetic therapeutics and peptide-conjugate treatments for patients with rare pediatric cancers and advanced solid tumours.

Thermosome

Thermosome develops heat-triggered targeted tumour therapies for cancer patients, focusing on treatment for soft tissue sarcomas.

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

ProteoValent Therapeutics

This company develops targeted protein degrader therapies for cancer and haematology patients.